USC.edu
Are You a Patient?

Neha Nanda, MD

Clinical Professor of Medicine (Clinician Educator), Hospital Epidemiologist and Medical Director of Antimicrobial Stewardship at Keck Medicine of USC, Chief of Infectious Diseases

Image of Neha Nanda, MD
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Overview

Dr. Nanda heads Healthcare Epidemiology/Infection Prevention and Antimicrobial Stewardship at Keck Medicine of USC and its affiliated hospitals and clinics. In this capacity, she leads Keck Medicine’s preparation and response for emerging infectious disease. In the last year, through the pandemic, she has led protocol and guideline development as it relates to patient and healthcare safety. Her research interests are geared towards infection prevention strategies and emerging pathogens. Her select publications include the impact of a multidisciplinary approach in reducing preventable harm, treatment strategies and diagnostics for C. difficile and biomarkers for appropriate antimicrobial use.

Awards

  • Society of Healthcare and Epidemiology of America: Jonathan Freeman Scholarship for Excellence in Healthcare Epidemiology Research, 2007
  • Yale University: William Wirt Winchester Research Fund Award for Tuberculosis Research, 2007
  • Yale University: Yale Infectious Diseases Collaborative Fund, 2007
  • Waterbury Hospital: In the Spotlight Award for Recognition of Efforts for Ebola Preparedness, 2015

Publications

  • Evogliptin prevents ceramide-induced pyroptosis during calcification via modulation of NLRP3/GSDM-D mediated pathway in Vascular Smooth Muscle Cells. PLoS One. 2025; 20(12):e0337200.. View in PubMed
  • Long COVID: A Systematic Review of Preventive Strategies. Infect Dis Rep. 2025 May 21; 17(3).. View in PubMed
  • New Diagnostics for Fungal Infections in Transplant Infectious Disease: A Systematic Review. J Fungi (Basel). 2025 Jan 09; 11(1).. View in PubMed
  • A Review of Therapies for Clostridioides difficile Infection. Antibiotics (Basel). 2024 Dec 31; 14(1).. View in PubMed
  • Somatic loss of ATM is a late event in pancreatic tumorigenesis. J Pathol. 2023 08; 260(4):455-464.. View in PubMed
  • A single-center review of pre-exposure prophylaxis with tixagevimab-cilgavimab in solid organ transplant recipients. Transpl Infect Dis. 2023 Aug; 25(4):e14086.. View in PubMed
  • Tixagevimab-Cilgavimab: Utilization in the solid organ transplant population. Clin Transplant. 2022 06; 36(6):e14661.. View in PubMed
  • Clostridioides difficile Toxin B PCR Cycle Threshold as a Predictor of Toxin Testing in Stool Specimens from Hospitalized Adults. Antibiotics (Basel). 2022 Apr 26; 11(5).. View in PubMed
  • Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance. Elife. 2022 01 10; 11.. View in PubMed
  • Leveraging implementation science to advance antibiotic stewardship practice and research. Infect Control Hosp Epidemiol. 2022 02; 43(2):139-146.. View in PubMed

Similar People